Search Results for: MARK1

16 interactions involving MARK1 - microtubule affinity regulating kinase 1 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
Novel CCR6 C-C motif chemokine receptor 6
  • Beta defensins
  • Chemokine receptors bind chemokines
  • G alpha (i) signalling events
Novel ESRRG estrogen related receptor gamma
  • Nuclear Receptor transcription pathway
  • Troglitazone
  • Diethylstilbestrol
  • Tamoxifen
  • Cholic Acid
  • Afimoxifene
  • 4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE
  • p-Cumylphenol
  • Bisphenol A
  • Bisphenol Z
  • Estradiol acetate
  • Estradiol benzoate
  • Estradiol cypionate
  • Estradiol dienanthate
  • Estradiol valerate
Novel KCNK2 potassium two pore domain channel subfamily K member 2
  • TWIK related potassium channel (TREK)
  • Phase 4 - resting membrane potential
  • Dofetilide
  • Dronedarone
Novel NIBAN1 niban apoptosis regulator 1
Novel TGFB2 transforming growth factor beta 2
  • Platelet degranulation
  • Molecules associated with elastic fibres
  • ECM proteoglycans
  • Graft-versus-host disease
  • Allograft rejection
Novel USH2A usherin
  • Usher syndrome (US)
  • Retinitis pigmentosa (RP)
CCDC102B coiled-coil domain containing 102B
GJA5 gap junction protein alpha 5
  • Gap junction assembly
  • Atrial fibrillation
INCA1 inhibitor of CDK, cyclin A1 interacting protein 1
MAP2 microtubule associated protein 2
  • Estramustine
  • Paclitaxel
  • Docetaxel
MAP4 microtubule associated protein 4
  • Paclitaxel
  • Docetaxel
  • Artenimol
MAPT microtubule associated protein tau
  • Caspase-mediated cleavage of cytoskeletal proteins
  • Lansoprazole
  • Astemizole
  • Paclitaxel
  • Docetaxel
  • Flortaucipir F-18
  • Amyotrophic lateral sclerosis (ALS); Lou Gehrig's disease
  • Frontotemporal lobar degeneration (FTLD), including: Pick disease of brain; Frontotemporal dementia (FTD); Ubiquitin-positive frontotemporal dementia (UP-FTD); Progressive supranuclear palsy type 1 (PSNP1); Inclusion body myopathy with early-onset paget disease and frontotemporal dementia (IBMPFD); Frontotemporal dementia, chromosome 3-linked (FTD3)
  • Progressive supranuclear palsy (PSP); Steele-Richardson-Olszewski syndrome
STK11 serine/threonine kinase 11
  • AMPK inhibits chREBP transcriptional activation activity
  • Energy dependent regulation of mTOR by LKB1-AMPK
  • Regulation of TP53 Activity through Phosphorylation
  • FOXO-mediated transcription of cell death genes
  • Peutz-Jeghers syndrome
  • Pancreatic cancer
TAOK1 TAO kinase 1
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • RHO GTPases Activate Formins
  • Mitotic Prometaphase
  • EML4 and NUDC in mitotic spindle formation
  • Fostamatinib
TCL1B TCL1 family AKT coactivator B
YAF2 YY1 associated factor 2
  • RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
  • Transcriptional Regulation by E2F6

Page 1 out of 1 pages